Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :894
Small font sizeDefault font sizeIncrease font size
Navigate Here
    Next article
    Previous article
    Table of Contents

Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed156    
    Printed1    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal

 

 EDITORIAL
Year : 2017  |  Volume : 54  |  Issue : 1  |  Page : 1

Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinib


Department of Pulmonary Medicine, ESI-PGIMSR, New Delhi, India

Correspondence Address:
Dr. D Gothi
Department of Pulmonary Medicine, ESI-PGIMSR, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijc.IJC_503_16

Rights and Permissions








[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow